These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38753402)

  • 21. CaMuS: simultaneous fitting and de novo imputation of cancer mutational signature.
    Cartolano M; Abedpour N; Achter V; Yang TP; Ackermann S; Fischer M; Peifer M
    Sci Rep; 2020 Nov; 10(1):19316. PubMed ID: 33168834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns and processes of somatic mutations in nine major cancers.
    Jia P; Pao W; Zhao Z
    BMC Med Genomics; 2014 Feb; 7():11. PubMed ID: 24552141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probabilistic non-negative matrix factorization: theory and application to microarray data analysis.
    Bayar B; Bouaynaya N; Shterenberg R
    J Bioinform Comput Biol; 2014 Feb; 12(1):1450001. PubMed ID: 24467759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A statistical framework for non-negative matrix factorization based on generalized dual divergence.
    Devarajan K
    Neural Netw; 2021 Aug; 140():309-324. PubMed ID: 33892302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of cancer mutational signatures on transcription factor motifs in the human genome.
    Yiu Chan CW; Gu Z; Bieg M; Eils R; Herrmann C
    BMC Med Genomics; 2019 May; 12(1):64. PubMed ID: 31109337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutational Signatures in Cancer (MuSiCa): a web application to implement mutational signatures analysis in cancer samples.
    Díaz-Gay M; Vila-Casadesús M; Franch-Expósito S; Hernández-Illán E; Lozano JJ; Castellví-Bel S
    BMC Bioinformatics; 2018 Jun; 19(1):224. PubMed ID: 29898651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MutVis: Automated framework for analysis and visualization of mutational signatures in pathogenic bacterial strains.
    Prasanna A; Niranjan V
    Infect Genet Evol; 2021 Jul; 91():104805. PubMed ID: 33689914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequent POLE-driven hypermutation in ovarian endometrioid cancer revealed by mutational signatures in RNA sequencing.
    Davila JI; Chanana P; Sarangi V; Fogarty ZC; Weroha SJ; Guo R; Goode EL; Huang Y; Wang C
    BMC Med Genomics; 2021 Jun; 14(1):165. PubMed ID: 34158040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relating mutational signature exposures to clinical data in cancers via signeR 2.0.
    Drummond RD; Defelicibus A; Meyenberg M; Valieris R; Dias-Neto E; Rosales RA; da Silva IT
    BMC Bioinformatics; 2023 Nov; 24(1):439. PubMed ID: 37990302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SparseSignatures: An R package using LASSO-regularized non-negative matrix factorization to identify mutational signatures from human tumor samples.
    Mella L; Lal A; Angaroni F; Maspero D; Piazza R; Sidow A; Antoniotti M; Graudenzi A; Ramazzotti D
    STAR Protoc; 2022 Sep; 3(3):101513. PubMed ID: 35779264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SigsPack, a package for cancer mutational signatures.
    Schumann F; Blanc E; Messerschmidt C; Blankenstein T; Busse A; Beule D
    BMC Bioinformatics; 2019 Sep; 20(1):450. PubMed ID: 31477009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. De novo mutational signature discovery in tumor genomes using SparseSignatures.
    Lal A; Liu K; Tibshirani R; Sidow A; Ramazzotti D
    PLoS Comput Biol; 2021 Jun; 17(6):e1009119. PubMed ID: 34181655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assigning mutational signatures to individual samples and individual somatic mutations with SigProfilerAssignment.
    Díaz-Gay M; Vangara R; Barnes M; Wang X; Islam SMA; Vermes I; Duke S; Narasimman NB; Yang T; Jiang Z; Moody S; Senkin S; Brennan P; Stratton MR; Alexandrov LB
    Bioinformatics; 2023 Dec; 39(12):. PubMed ID: 38096571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonnegative matrix factorization with the Itakura-Saito divergence: with application to music analysis.
    Févotte C; Bertin N; Durrieu JL
    Neural Comput; 2009 Mar; 21(3):793-830. PubMed ID: 18785855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A site specific model and analysis of the neutral somatic mutation rate in whole-genome cancer data.
    Bertl J; Guo Q; Juul M; Besenbacher S; Nielsen MM; Hornshøj H; Pedersen JS; Hobolth A
    BMC Bioinformatics; 2018 Apr; 19(1):147. PubMed ID: 29673314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unsupervised detection of fragment length signatures of circulating tumor DNA using non-negative matrix factorization.
    Renaud G; Nørgaard M; Lindberg J; Grönberg H; De Laere B; Jensen JB; Borre M; Andersen CL; Sørensen KD; Maretty L; Besenbacher S
    Elife; 2022 Jul; 11():. PubMed ID: 35894300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of nonnegative matrix factorization algorithms for electroencephalography spectral analysis.
    Hu G; Zhou T; Luo S; Mahini R; Xu J; Chang Y; Cong F
    Biomed Eng Online; 2020 Jul; 19(1):61. PubMed ID: 32736630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sparse data embedding and prediction by tropical matrix factorization.
    Omanović A; Kazan H; Oblak P; Curk T
    BMC Bioinformatics; 2021 Feb; 22(1):89. PubMed ID: 33632116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance and limitations of the use of next-generation sequencing technologies for detecting mutational signatures.
    Abbasi A; Alexandrov LB
    DNA Repair (Amst); 2021 Nov; 107():103200. PubMed ID: 34411908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational signatures: the patterns of somatic mutations hidden in cancer genomes.
    Alexandrov LB; Stratton MR
    Curr Opin Genet Dev; 2014 Feb; 24(100):52-60. PubMed ID: 24657537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.